A Practical Approach to MRI: Stability or High Relaxivity?
In this CME/CE accredited program Dr. Howard Rowley reviews important efficacy considerations of the FDA approved gadolinium-based contrast agents (GBCAs), including clinical utility, safety issues, and practical approaches for selecting a GBCA when considering patient history, pathology and related risks. Following Dr. Rowley’s presentation, a group of MR imaging experts will engage in a panel discussion in support of this important topic.
Educational Credits
- One (1) AMA PRA Category 1 CME Credits™
- One (1) ARRT Category A CE Credits
- One (1) AHRA CRA Credit
Learning Objectives
- List the key considerations in the choice of GBCAs, while balancing safety and efficacy.
- Describe the transient effects of T1 and T2 relaxation during a GBCA bolus.
- Understand the impact of high relaxivity gadolinium agents vs macrocyclic agents.
- Design MRI protocols to optimize exam efficiency and enhanced lesion detection.
- Implement GBCA protocols for special patient populations after considering risk assessment.